About US
Contact us
-
WHO and FIP sign landmark tuberculosis initiativeThe World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) have signed a landmark initiative to improve engagement between pharmacists and tuberculosis health workers.2011/9/7
-
"National Safe Medication Month" campaign launched"National Safe Medication Month" campaign was launched in an all-round way on September 1, 2011. The theme of this years activity is "beware of online fraud selling counterfeit drugs". Centering on th2011/9/5
-
SFDA issues Operating Standards for Food Safety in Catering ServicesThe State Food and Drug Administration (SFDA) recently formally issued the Operating Standards for Food Safety in Catering Services to further raise the food safety awareness, integrity awareness and2011/9/2
-
FDA urged to revise generic drug risk rulesThe US Food and Drug Administration (FDA) has been urged to amend regulations preventing generic drug manufacturers from updating labelling, allowing them to warn patients about associated drug risks.2011/9/2
-
Study reveals how pharmaceutical managers can maximize the return on marketing investmentsModel depicts that detailing, relationships between sales representatives and medical doctors, is an extremely effective long-term marketing tool, while sampling has a stronger, short-term effect Res2011/9/1
-
FDA rejects Novartis gout medicationThe US Food and Drug Administration (FDA) has rejected canakinumab, a drug developed by Novatis to treat gout. The decision follows an 11-1 vote against approving the drug to treat gouty arthritis2011/8/31
-
US hospitals turning to gray-market vendorsHalf of US hospitals are turning to gray-market vendors as the country's drug shortage continues, a new survey has shown. The Institute for Safe Medication Practices (ISMP) has issued a safety aler2011/8/31
-
Pfizer receives FDA approval of XALKORI for ALK-positive NSCLCPfizer Inc. has received FDA approval of XALKORI® (crizotinib) capsules - the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC2011/8/30
-
Researchers identify molecule that can stop the formation of amyloid fibrilsA molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Lee2011/8/29
-
Pfizer, Abbott receive FDA approval for Xalkori, Vysis ALK FISH test to treat NSCLCThe U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express th2011/8/29